How to read this definition
Inclusion criteria describe evidence that can establish this activity. Exclusion criteria identify circumstances that do not establish it on that basis alone. The evaluation remains connected to its taxonomy version and supporting evidence.
Can establish this activity
Included when supported
Evidence may support involvement when it matches one or more of these inclusion criteria.
7 criteria
- 01Criterion
Include licensed or otherwise authorized cultivators producing cannabis for recreational or adult use.
- 02Criterion
Include manufacturers and processors of recreational cannabis flower, extracts, concentrates, oils, vapes, edibles, beverages, and other adult-use products.
- 03Criterion
Include licensed recreational-cannabis dispensaries, stores, e-commerce sellers, and other direct consumer retailers.
- 04Criterion
Include brand owners and consumer-products companies with direct commercial responsibility for recreational cannabis or psychoactive cannabinoid products.
- 05Criterion
Include extractors, processors, and contract manufacturers directly handling products for the recreational market.
- 06Criterion
Include licensed wholesalers and distributors of recreational cannabis products.
- 07Criterion
Include manufacturers of cannabis beverages, edibles, vapour products, and other adult-use formats.
Does not establish this activity on its own
Excluded on this basis alone
These circumstances do not establish this activity unless separate evidence also meets an inclusion criterion.
6 criteria
- 01Criterion
Exclude activity limited to medical, prescription, or pharmaceutical cannabis and cannabinoid products.
- 02Criterion
Exclude industrial hemp cultivated or processed solely for fibre, grain, seed, food, construction, or other non-recreational purposes.
- 03Criterion
Exclude non-intoxicating CBD and wellness products where the evidence does not establish recreational, adult-use, or psychoactive positioning.
- 04Criterion
Exclude real estate, finance, packaging, lighting, software, consulting, security, advertising, and other ancillary services without direct product handling or commercial rights.
- 05Criterion
Exclude approved or investigational cannabinoid medicines supplied solely for medical use.
- 06Criterion
Exclude academic research, advocacy, policy organizations, and non-commercial activity.
Evidence and evaluation methodology
How sources, entity pathways, decisions, qualifiers, and review history are handled.
Map screens to a client policy
How to choose provider screens, document coverage, and decide what happens after an outcome.